Author: Richard Atkins

Richard Atkins is a senior contributor at Tech Insider covering online media, online travel, and video games. Richard has been with Tech Insider covering companies in these industries since 2011 and has authored numerous industry reports, including "Internet Video: Field of Dreams or Nightmare on Elm Street," "The Next Leg of Online Travel," and "Pwned: How Casual Games Changed The Gaming Landscape." Atkins was recognized as the No. 2 stock picker and earnings estimator in the 2011 Financial Times / StarMine Internet & Catalog Retail category and was ranked in the 2010 Wall Street Journal "Best On The Street" for the Leisure Goods & Services category.
BioTech

Unusual Volume Biotech Stocks: Compugen Ltd (NASDAQ:CGEN), Sinovac Biotech (NASDAQ:SVA), Enzymotec (NASDAQ:ENZY), Cempra (NASDAQ:CEMP)

Over the past three years, using its in-silico discovery platform for predictive drug discovery (i.e. computer models and algorithms), Compugen Ltd. (USA) (NASDAQ:CGEN) has developed a hugely compelling drug Pipeline across several clinical areas. Compugen Ltd. (USA) (NASDAQ:CGEN) stock performance was -20.14% in last session and finished the day at $11.34. Traded volume was 22,668.00 shares in the last session and the average volume of … Continue reading Unusual Volume Biotech Stocks: Compugen Ltd (NASDAQ:CGEN), Sinovac Biotech (NASDAQ:SVA), Enzymotec (NASDAQ:ENZY), Cempra (NASDAQ:CEMP)

Richard Atkins
Finance, Internet

Stock in Action: Facebook (NASDAQ FB) Stock Report: Q4 Reactions and More

Facebook (NASDAQ FB) has been going from strength to strength. The biggest social networking site of the world is increasing its user base which is already more than a billion. Despite recent reports of a slowdown in the growth of the number of users, Facebook has indeed posted a great earnings and revenue report for the last financial quarter. Facebook FB Stock has certainly done … Continue reading Stock in Action: Facebook (NASDAQ FB) Stock Report: Q4 Reactions and More

Richard Atkins
Finance, Internet

Stock in News: A Look At the Potential of Apple (NASDAQ AAPL) Stock

Apple has been phenomenal in the past few months. After touching a record high at the start of this year, the AAPL stock has been rallying around the levels of $125. Despite such high levels, various analysts have been pinning Apple to perform well and reach even higher levels. In fact, the belief in the market is such that Apple stock is a must have … Continue reading Stock in News: A Look At the Potential of Apple (NASDAQ AAPL) Stock

Richard Atkins
Finance, internet

Stock in News: Why Microsoft (NASDAQ MSFT) Windows 10 Has Loads of Potential

Microsoft (NASDAQ MSFT) has been a completely different stock under the leadership of Satya Nadella. Since the closing stages of last year, the stock has been on a roll and has touched some of its major peaks. The cloud first, mobile first strategy of Microsoft seems to be working well. In such circumstances, it would be intriguing to see how Microsoft’s bread and butter product … Continue reading Stock in News: Why Microsoft (NASDAQ MSFT) Windows 10 Has Loads of Potential

Richard Atkins
Gilead Sciences GILD NASDAQ:GILD
Financial

Earnings Event to Watch for on Friday: 3D Systems Corporation (NYSE:DDD), Newcastle Investment Corp (NYSE:NCT)

3D Systems Corporation (NYSE:DDD) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement. Historical earnings event related premarket and after-hours trading activity in DDD indicates that the price change in the extended hours is likely to be of limited value in forecasting additional price … Continue reading Earnings Event to Watch for on Friday: 3D Systems Corporation (NYSE:DDD), Newcastle Investment Corp (NYSE:NCT)

Richard Atkins
Analysis, BioTech, business, Earnings, Finance

Earnings on Tap After-Market – Valeant Pharmaceuticals International (NYSE:VRX), Sotheby’s Holdings Inc (NYSE: BID)

Valeant Pharmaceuticals International (NYSE:VRX) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement. Historical earnings event related premarket and after-hours trading activity in VRX indicates that the price change in the extended hours is likely to be of limited value in forecasting additional price … Continue reading Earnings on Tap After-Market – Valeant Pharmaceuticals International (NYSE:VRX), Sotheby’s Holdings Inc (NYSE: BID)

Richard Atkins